PL3440205T3 - Nieinwazyjna diagnostyka poprzez sekwencjonowanie 5-hydroksymetylowanego dna bezkomórkowego - Google Patents

Nieinwazyjna diagnostyka poprzez sekwencjonowanie 5-hydroksymetylowanego dna bezkomórkowego

Info

Publication number
PL3440205T3
PL3440205T3 PL17779593T PL17779593T PL3440205T3 PL 3440205 T3 PL3440205 T3 PL 3440205T3 PL 17779593 T PL17779593 T PL 17779593T PL 17779593 T PL17779593 T PL 17779593T PL 3440205 T3 PL3440205 T3 PL 3440205T3
Authority
PL
Poland
Prior art keywords
sequencing
free dna
hydroxymethylated
cell
noninvasive diagnostics
Prior art date
Application number
PL17779593T
Other languages
English (en)
Inventor
Stephen R. Quake
Chunxiao Song
Original Assignee
The Board Of Trustees Of The Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The Leland Stanford Junior University filed Critical The Board Of Trustees Of The Leland Stanford Junior University
Publication of PL3440205T3 publication Critical patent/PL3440205T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855Ligating adaptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/191Modifications characterised by incorporating an adaptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/185Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/04Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
PL17779593T 2016-04-07 2017-04-03 Nieinwazyjna diagnostyka poprzez sekwencjonowanie 5-hydroksymetylowanego dna bezkomórkowego PL3440205T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662319702P 2016-04-07 2016-04-07
US201762444122P 2017-01-09 2017-01-09
US201762461712P 2017-02-21 2017-02-21
PCT/US2017/025735 WO2017176630A1 (en) 2016-04-07 2017-04-03 Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna
EP17779593.7A EP3440205B1 (en) 2016-04-07 2017-04-03 Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna

Publications (1)

Publication Number Publication Date
PL3440205T3 true PL3440205T3 (pl) 2021-11-22

Family

ID=60000634

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17779593T PL3440205T3 (pl) 2016-04-07 2017-04-03 Nieinwazyjna diagnostyka poprzez sekwencjonowanie 5-hydroksymetylowanego dna bezkomórkowego

Country Status (13)

Country Link
US (7) US10718010B2 (pl)
EP (2) EP3440205B1 (pl)
JP (2) JP7143221B2 (pl)
CN (1) CN109312399B (pl)
AU (1) AU2017246318B2 (pl)
DK (1) DK3440205T3 (pl)
ES (1) ES2882329T3 (pl)
MX (1) MX391039B (pl)
PL (1) PL3440205T3 (pl)
PT (1) PT3440205T (pl)
RU (1) RU2742355C2 (pl)
SG (1) SG11201808775PA (pl)
WO (1) WO2017176630A1 (pl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
ES2669214T3 (es) 2011-12-13 2018-05-24 Oslo Universitetssykehus Hf Procedimientos y kits para la detección de estado de metilación
ES2786984T3 (es) 2012-11-30 2020-10-14 Cambridge Epigenetix Ltd Agente oxidante para nucleótidos modificados
ES2859645T3 (es) 2013-03-14 2021-10-04 Mayo Found Medical Education & Res Detección de neoplasia
CA2912666A1 (en) 2013-05-28 2014-12-04 Ramot At Tel-Aviv University Ltd. Detection of hydroxymethylcytosine bases
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
WO2016160454A1 (en) 2015-03-27 2016-10-06 Exact Sciences Corporation Detecting esophageal disorders
KR20250172724A (ko) 2015-08-31 2025-12-09 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 위 신생물 검출 방법
WO2017059245A2 (en) 2015-09-30 2017-04-06 Trustees Of Boston University Deadman and passcode microbial kill switches
US20170298422A1 (en) 2016-04-18 2017-10-19 The Board Of Trustees Of The Leland Stanford Junior University Simultaneous single-molecule epigenetic imaging of dna methylation and hydroxymethylation
JP2021500883A (ja) 2017-10-27 2021-01-14 ジュノ ダイアグノスティックス,インク. 超微量リキッドバイオプシーのためのデバイス、システム、および方法
CN111971386A (zh) 2018-01-08 2020-11-20 路德维格癌症研究院 胞嘧啶修饰的免亚硫酸氢盐的碱基分辨率鉴定
CN112105626A (zh) 2018-02-14 2020-12-18 蓝星基因组股份有限公司 用于dna、特别是细胞游离dna的表观遗传学分析的方法
WO2019173552A1 (en) 2018-03-08 2019-09-12 St. John's University Circulating serum cell-free dna biomarkers and methods
CA3095030A1 (en) 2018-03-30 2019-10-03 Juno Diagnostics, Inc. Deep learning-based methods, devices, and systems for prenatal testing
AU2019249422B2 (en) 2018-04-02 2025-09-25 Grail, Inc. Methylation markers and targeted methylation probe panels
EP4647512A2 (en) 2018-06-22 2025-11-12 ClearNote Health, Inc. Hydroxymethylation analysis of cell-free nucleic acid samples for assigning tissue of origin, and related methods of use
WO2020061380A1 (en) 2018-09-19 2020-03-26 Bluestar Genomics, Inc. Cell-free dna hydroxymethylation profiles in the evaluation of pancreatic lesions
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
MX2021003847A (es) 2018-10-04 2021-05-27 Bluestar Genomics Inc Analisis simultaneo de proteinas, nucleosomas y acidos nucleicos libres de celula, basado en secuenciacion, de una muestra biologica individual.
CN112867495B (zh) * 2018-10-19 2024-08-20 韩国生命工学研究院 包含syt11抑制剂作为活性成分的胃癌治疗组合物
CN109321647A (zh) * 2018-10-26 2019-02-12 苏州森苗生物科技有限公司 标记组合物及羟甲基化核酸文库的构建方法
WO2020154665A1 (en) 2019-01-24 2020-07-30 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
CA3126428A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
WO2020194057A1 (en) * 2019-03-22 2020-10-01 Cambridge Epigenetix Limited Biomarkers for disease detection
AU2020245532A1 (en) * 2019-03-27 2021-11-11 Juno Diagnostics, Inc. Optimized ultra-low volume liquid biopsy methods, systems, and devices
WO2020263978A1 (en) * 2019-06-25 2020-12-30 Accuragen Holdings Limited Methods and systems for disease detection
CN114174534B (zh) 2019-07-08 2025-03-25 路德维格癌症研究所 免亚硫酸氢盐的全基因组甲基化分析
EP4010492B1 (en) * 2019-08-06 2026-04-15 Oxford Nanopore Technologies plc Recapturing a polynucleotide in a nanopore device
US11702704B2 (en) 2019-10-31 2023-07-18 Mayo Foundation For Medical Education And Research Detecting ovarian cancer
EP4103743A1 (en) 2020-02-11 2022-12-21 Ludwig Institute for Cancer Research Ltd Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
EP4127223A1 (en) * 2020-03-30 2023-02-08 Vilnius University Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of genomic sites
JP2023528946A (ja) * 2020-06-10 2023-07-06 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 臓器の組織学的データを評価するための方法及び関連装置
CA3187549A1 (en) 2020-07-30 2022-02-03 Cambridge Epigenetix Limited Compositions and methods for nucleic acid analysis
JP2023539128A (ja) 2020-08-19 2023-09-13 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 非ホジキンリンパ腫の検出
CA3199829A1 (en) * 2020-11-30 2022-06-02 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
CN114613423A (zh) * 2020-12-09 2022-06-10 上海易毕恩基因科技有限公司 用于弥漫大b细胞淋巴瘤化疗疗效预测的生物标志物
KR20230150814A (ko) 2021-01-29 2023-10-31 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 다양한 유형의 암에 대한 존재 또는 부재의 검출
CN118265801A (zh) * 2021-07-20 2024-06-28 福瑞诺姆控股公司 提高核酸测序中5-羟甲基化胞嘧啶分辨率的组合物和方法
CN113528616A (zh) * 2021-07-26 2021-10-22 深圳泰莱生物科技有限公司 一种捕获cfDNA5hmC片段的检测方法
WO2023040997A1 (zh) * 2021-09-17 2023-03-23 北京大学 一种单基因检测方法及其应用
JP2024538697A (ja) * 2021-10-08 2024-10-23 マイクロノーマ,インク. メタエピゲノミクスベースの疾患診断法
CN115992203B (zh) * 2022-07-26 2024-07-26 生工生物工程(上海)股份有限公司 一种全基因组羟甲基化捕获测序的文库构建方法
CN115491414A (zh) * 2022-09-21 2022-12-20 安徽中医药大学第一附属医院(安徽省中医院) 类风湿关节炎全转录组m6A甲基化修饰差异表达的综合分析方法
EP4655416A1 (en) 2023-01-25 2025-12-03 Guardant Health, Inc. Nucleic acid methylation profiling method
WO2024197287A1 (en) 2023-03-22 2024-09-26 Clearnote Health, Inc. Cell-free dna analysis in the detection and monitoring of pancreatic cancer using a combination of features
WO2026024692A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Direct methylation single-base resolution sequencing of enriched unmethylated dna
WO2026024956A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Selecting low technical noise biomarkers for sensitive molecular diagnostics
WO2026043702A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods and approaches for personalized identification and monitoring of extrachromosomal circular dna
WO2026050179A1 (en) 2024-08-26 2026-03-05 Guardant Health, Inc. Tumor fraction (tf) is associated with real-world progression-free survival (rwpfs) in non-small-cell lung cancer (nsclc) patients treated with platinum-based chemotherapy (chemo)
WO2026050287A1 (en) 2024-08-27 2026-03-05 Guardant Health, Inc. Methylation biomarkers for osimertinib treatment management

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712126A (en) 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
US6287825B1 (en) 1998-09-18 2001-09-11 Molecular Staging Inc. Methods for reducing the complexity of DNA sequences
US20050233340A1 (en) 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for assessing CpG methylation
US20100273151A1 (en) * 2004-05-28 2010-10-28 Fred Hutchinson Cancer Research Center Genome-wide analysis of palindrome formation and dna methylation
AU2006254834B2 (en) * 2005-06-08 2012-09-20 Millennium Pharmaceuticals, Inc. Treatment of patients with cancer therapy
WO2007087312A2 (en) 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Molecular counting
WO2008150432A1 (en) 2007-06-01 2008-12-11 454 Life Sciences Corporation System and meth0d for identification of individual samples from a multiplex mixture
US20090093378A1 (en) 2007-08-29 2009-04-09 Helen Bignell Method for sequencing a polynucleotide template
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
US8541207B2 (en) * 2008-10-22 2013-09-24 Illumina, Inc. Preservation of information related to genomic DNA methylation
US20100323348A1 (en) 2009-01-31 2010-12-23 The Regents Of The University Of Colorado, A Body Corporate Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process
DK2414544T3 (da) * 2009-04-01 2014-06-16 Dxterity Diagnostics Inc Probe-amplifikations-afhængig kemisk ligering
WO2011025819A1 (en) * 2009-08-25 2011-03-03 New England Biolabs, Inc. Detection and quantification of hydroxymethylated nucleotides in a polynucleotide preparation
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
DE112011100297B4 (de) * 2010-01-20 2017-08-24 New England Biolabs, Inc. Zusammensetzungen, Verfahren und damit in Zusammenhang stehende Anwendungen zum Spalten modifizierter DNA
WO2011127136A1 (en) 2010-04-06 2011-10-13 University Of Chicago Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc)
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
EP2619327B1 (en) 2010-09-21 2014-10-22 Population Genetics Technologies LTD. Increasing confidence of allele calls with molecular counting
US20120122087A1 (en) * 2010-11-17 2012-05-17 Weiwei Li 5-Hydroxymethylcytosine as a biomarker for early detection, treatment and prognostic monitoring of cancer
US9611510B2 (en) * 2011-04-06 2017-04-04 The University Of Chicago Composition and methods related to modification of 5-methylcytosine (5-mC)
AU2012242847B2 (en) 2011-04-15 2017-01-19 The Johns Hopkins University Safe sequencing system
HUE053360T2 (hu) 2012-02-17 2021-06-28 Hutchinson Fred Cancer Res Kompozíciók és eljárások mutációk pontos azonosítására
ES2828661T3 (es) 2012-03-20 2021-05-27 Univ Washington Through Its Center For Commercialization Métodos para reducir la tasa de error de la secuenciación de ADN masiva en paralelo mediante el uso de la secuenciación de secuencia consenso bicatenaria
US9732390B2 (en) * 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
CA2892617C (en) * 2012-11-26 2017-01-24 The University Of Toledo Methods for standardized sequencing of nucleic acids and uses thereof
WO2014168711A1 (en) * 2013-03-13 2014-10-16 Sequenom, Inc. Primers for dna methylation analysis
WO2015021282A1 (en) * 2013-08-09 2015-02-12 New England Biolabs, Inc. Detecting, sequencing and/or mapping 5-hydroxymethylcytosine and 5-formylcytosine at single-base resolution
ES2805004T3 (es) * 2013-08-19 2021-02-10 Abbott Molecular Inc Análogos de nucleótidos
AU2015205612B2 (en) * 2014-01-07 2020-12-03 Llorenc Coll Mulet Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines
CA2938451C (en) * 2014-01-30 2023-10-17 The Regents Of The University Of California Methylation haplotyping for non-invasive diagnosis (monod)
GB201405226D0 (en) * 2014-03-24 2014-05-07 Cambridge Entpr Ltd Nucleic acid preparation method
EP4170044B1 (en) * 2014-06-06 2026-03-11 Cornell University Method for identification and enumeration of nucleic acid sequence, expression, copy, or dna methylation changes, using combined nuclease, ligase, polymerase, and sequencing reactions
EP2975116B1 (en) * 2014-07-16 2019-08-21 Max-Delbrück-Centrum für Molekulare Medizin Tgif2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof
US20180046754A1 (en) * 2015-03-24 2018-02-15 Agency For Science, Technology And Research (A*Star) Normalization methods for measuring gene copy number and expression
US11162139B2 (en) 2016-03-02 2021-11-02 Shanghai Epican Genetech Co. Ltd. Method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine

Also Published As

Publication number Publication date
US20200248248A1 (en) 2020-08-06
CN109312399A (zh) 2019-02-05
RU2018138848A3 (pl) 2020-12-15
EP3929290A1 (en) 2021-12-29
EP3440205A1 (en) 2019-02-13
WO2017176630A1 (en) 2017-10-12
PT3440205T (pt) 2021-08-06
MX2018012156A (es) 2019-02-07
US20200283838A1 (en) 2020-09-10
US20200299760A1 (en) 2020-09-24
AU2017246318B2 (en) 2023-07-27
US20200277667A1 (en) 2020-09-03
EP3440205A4 (en) 2019-04-03
US20200277666A1 (en) 2020-09-03
JP2019520791A (ja) 2019-07-25
ES2882329T3 (es) 2021-12-01
AU2017246318A2 (en) 2018-11-08
JP7143221B2 (ja) 2022-09-28
SG11201808775PA (en) 2018-11-29
CA3019836A1 (en) 2017-10-12
DK3440205T3 (da) 2021-08-16
EP3440205B1 (en) 2021-05-26
US10718010B2 (en) 2020-07-21
RU2742355C2 (ru) 2021-02-05
AU2017246318A1 (en) 2018-11-08
RU2018138848A (ru) 2020-05-12
US20200248249A1 (en) 2020-08-06
US20190017109A1 (en) 2019-01-17
JP2022120007A (ja) 2022-08-17
MX391039B (es) 2025-03-21
CN109312399B (zh) 2023-02-03

Similar Documents

Publication Publication Date Title
PT3440205T (pt) Diagnóstico não invasivo através da sequenciação de dna 5- hidroximetilado sem células
ZA201802493B (en) Representative diagnostics
ZA201704231B (en) Chimeric protein
EP3218519A4 (en) Multi-pass sequencing
EP3234128A4 (en) Sequencing controls
GB201614873D0 (en) Autonomous driving certification generalizer
SG11201609754QA (en) Sequencing process
GB201506223D0 (en) Chimeric protein
GB201511969D0 (en) Biosensor
SG10201404895XA (en) Diagnosis
ZA201702351B (en) Revaprazan hydrochloride polymorphs and preparation method therefor.
PL3190964T3 (pl) Spirometr
PT3129499T (pt) Controlos universais para ensaios de sequenciação
GB201508860D0 (en) Diagnostic method
GB201409851D0 (en) Diagnostic method
GB201615753D0 (en) Diagnostic method
PL3169295T3 (pl) Krata boczna o ruchu współbieżnym
GB201504297D0 (en) Diagnosis
GB201509658D0 (en) Method of diagnosis
GB201408875D0 (en) Diagnostic method
EP3535421C0 (en) DIAGNOSTIC PROCEDURES
GB201615330D0 (en) Method of diagnosis
GB201510033D0 (en) Asymmetric addition reactions
GB201412131D0 (en) Diagnostics
GB201516557D0 (en) Diagnosis